BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7024111)

  • 1. A method for rapid determination of IgG containing circulating immune complexes using polyethyleneglycol and radioactively labeled protein A.
    Stevens WJ; Bridts C
    Immunol Lett; 1981 Apr; 3(1):1-4. PubMed ID: 7024111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
    Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
    Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
    J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
    Hack CE; Belmer AJ
    Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the soluble immune complexes that are detected by three different techniques.
    van der Giessen M; The TH
    Clin Immunol Immunopathol; 1986 Feb; 38(2):244-55. PubMed ID: 3484441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and quantitation of circulating immune complexes by the C1q-protein A binding assay (C1q-PABA).
    Glikmann G; Svehag SE
    Methods Enzymol; 1981; 74 Pt C():571-88. PubMed ID: 6798369
    [No Abstract]   [Full Text] [Related]  

  • 7. Polyethylene glycol enhances the binding of C1q to circulating immune complexes.
    Hack CE; Eerenberg-Belmer AJ; Hannema AJ; Out TA; Aalberse RC
    J Immunol Methods; 1981; 44(2):211-21. PubMed ID: 6792284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgG binding test to assay circulating IgG-containing immune complexes from polyethylene glycol precipitates.
    Levinson SS; Goldman JO; Feldkamp CS
    Clin Chem; 1984 Sep; 30(9):1502-6. PubMed ID: 6235980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the binding of C1q to immune complexes by polyethylene glycol.
    Wines BD; Easterbrook-Smith SB
    Mol Immunol; 1988 Mar; 25(3):263-6. PubMed ID: 3259672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ability to activate complement is not required for the detection of immune complexes by the fluid-phase C1q binding assay.
    Fiocco GP; Davis JS; Burge JJ
    Arthritis Rheum; 1985 Feb; 28(2):222-5. PubMed ID: 3871617
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune complexes in normal subjects.
    Simpson IJ; Myles MJ; Smith GW
    J Clin Lab Immunol; 1983 Jul; 11(3):119-22. PubMed ID: 6350590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
    Nydegger UE; Lambert PH; Gerber H; Miescher PA
    J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A method of isolating C1q from human serum and its use in the solid-phase immunoenzyme determination of immune complexes].
    Belozerov AP
    Lab Delo; 1989; (3):24-6. PubMed ID: 2469833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo reduction of circulating C1q binding immune complexes by intravenous gammaglobulin administration.
    Lin RY; Racis SP
    Int Arch Allergy Appl Immunol; 1986; 79(3):286-90. PubMed ID: 2419257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complex assays and their limitations.
    Kilpatrick DC; Weston J
    Med Lab Sci; 1985 Apr; 42(2):178-85. PubMed ID: 2933572
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-IgG type test to assay circulating immune complexes from polyethylene glycol precipitates compared with C1q binding and Raji cell tests.
    Levinson SS; Goldman J
    Clin Biochem; 1984 Dec; 17(6):341-4. PubMed ID: 6335066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significances of circulating immune complexes in connective tissue diseases--detection by C1q deviation test, precipitin reaction of C1q in gel diffusion, anti-antibody inhibition test and precipitation with polyethylene glycol].
    Yasuda M
    Ryumachi; 1983 Oct; 23(5):315-26. PubMed ID: 6608796
    [No Abstract]   [Full Text] [Related]  

  • 19. Porcine C1q and the solid-phase immunoassay of human immune complexes.
    Ziola B; Salmi A; Penttinen K
    J Immunol Methods; 1982 Mar; 49(3):247-60. PubMed ID: 6978362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric detection and quantitation of immune complexes using human C1q-coated microspheres.
    McHugh TM; Stites DP; Casavant CH; Fulwyler MJ
    J Immunol Methods; 1986 Dec; 95(1):57-61. PubMed ID: 3491163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.